Progress in diagnosis and treatment of mantle cell lymphoma
10.3760/cma.j.issn.1009-9921.2016.10.019
- VernacularTitle:套细胞淋巴瘤诊治进展
- Author:
Gege CHEN
;
Jumei SHI
;
Yiwen ZHANG
- Publication Type:Journal Article
- Keywords:
Lymphoma,mantle cell;
Lymphoma,non-Hodgkin;
Diagnosis;
Treatment
- From:
Journal of Leukemia & Lymphoma
2016;25(10):637-640
- CountryChina
- Language:Chinese
-
Abstract:
Mantle cell lymphoma (MCL) is a group of highly aggressive non-Hodgkin lymphoma (NHL) in small B-cell lymphoma, accounting for 6 % of NHL incidence. MCL is characterized with its concealed onset, strong aggression, high malignancy and poor prognosis. Therefore, more attention should be paid to the diagnosis and differential diagnosis of MCL in clinic. Recently, diagnostic models of molecular pathology, researches on cyclin D1 protein negative MCL, staging prognosis and stratification treatment of MCL are worthy of attention.
